156 related articles for article (PubMed ID: 26402401)
1. Immunotherapy for glioblastoma: concepts and challenges.
Weiss T; Weller M; Roth P
Curr Opin Neurol; 2015 Dec; 28(6):639-46. PubMed ID: 26402401
[TBL] [Abstract][Full Text] [Related]
2. Perspectives for immunotherapy in glioblastoma treatment.
Finocchiaro G; Pellegatta S
Curr Opin Oncol; 2014 Nov; 26(6):608-14. PubMed ID: 25210870
[TBL] [Abstract][Full Text] [Related]
3. Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A; Heilinger T; Lavelle EC; Prehn JH
J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
[TBL] [Abstract][Full Text] [Related]
4. Current challenges in designing GBM trials for immunotherapy.
Weathers SP; Gilbert MR
J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
[TBL] [Abstract][Full Text] [Related]
5. Prospects of immune checkpoint modulators in the treatment of glioblastoma.
Preusser M; Lim M; Hafler DA; Reardon DA; Sampson JH
Nat Rev Neurol; 2015 Sep; 11(9):504-14. PubMed ID: 26260659
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell immunotherapy for glioblastoma.
Polyzoidis S; Ashkan K
Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy.
Lu J; Lee-Gabel L; Nadeau MC; Ferencz TM; Soefje SA
J Oncol Pharm Pract; 2015 Dec; 21(6):451-67. PubMed ID: 24917416
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms.
Quinn DI; Shore ND; Egawa S; Gerritsen WR; Fizazi K
Urol Oncol; 2015 May; 33(5):245-60. PubMed ID: 25575714
[TBL] [Abstract][Full Text] [Related]
9. The progress of immunotherapy for glioblastoma.
Zhou Q; Wang Y; Ma W
Hum Vaccin Immunother; 2015; 11(11):2654-8. PubMed ID: 26308501
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein-peptide complex in the treatment of glioblastoma.
See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in human glioblastoma.
Szabo AT; Carpentier AF
Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.
Kim ES; Kim JE; Patel MA; Mangraviti A; Ruzevick J; Lim M
J Immunol Res; 2016; 2016():4683607. PubMed ID: 26881264
[TBL] [Abstract][Full Text] [Related]
13. Immunological challenges for peptide-based immunotherapy in glioblastoma.
Mohme M; Neidert MC; Regli L; Weller M; Martin R
Cancer Treat Rev; 2014 Mar; 40(2):248-58. PubMed ID: 24064197
[TBL] [Abstract][Full Text] [Related]
14. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
15. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
16. Overview of current immunotherapeutic strategies for glioma.
Calinescu AA; Kamran N; Baker G; Mineharu Y; Lowenstein PR; Castro MG
Immunotherapy; 2015; 7(10):1073-104. PubMed ID: 26598957
[TBL] [Abstract][Full Text] [Related]
17. An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.
Reardon DA; Wucherpfennig KW; Freeman G; Wu CJ; Chiocca EA; Wen PY; Curry WT; Mitchell DA; Fecci PE; Sampson JH; Dranoff G
Expert Rev Vaccines; 2013 Jun; 12(6):597-615. PubMed ID: 23750791
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches and mechanisms of immunotherapy for glioblastoma.
Hegde M; Bielamowicz KJ; Ahmed N
Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
[TBL] [Abstract][Full Text] [Related]
19. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy advances for glioblastoma.
Reardon DA; Freeman G; Wu C; Chiocca EA; Wucherpfennig KW; Wen PY; Fritsch EF; Curry WT; Sampson JH; Dranoff G
Neuro Oncol; 2014 Nov; 16(11):1441-58. PubMed ID: 25190673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
